Milestones in the Course of Parkinson's Disease

被引:0
|
作者
Reichmann, H. [1 ]
机构
[1] Tech Univ Dresden, Klin & Poliklin Neurol, Univ Klinikum Carl Gustav Carus, D-01307 Dresden, Germany
关键词
Parkinson's disease; non-motor symptoms; dementia; Braak staging; PROGRESSION; PATHOLOGY; DYSFUNCTION; SIGN;
D O I
10.1055/s-0031-1299709
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease is a progressive neurodegenerative disorder. There are various ways to describe the severity and progresion of the disease. For clincal purposes the Hoehn and Yahr staging is still the mostly used, whereas the Braak staging is the best neuropathological staging. Using neuroanatomic analyses, clinical follow-up and technical investigations with SPEC and PET some typical milestones of Parkinson's disease have been established. At onset the cell death of dopaminergic neurons is high which is not noted by the patients due to the fact that motor symptoms do not occur until the patients have lost more than 60% of their nigral dopaminergic cells. In this prodromal phase non-motor symptoms such as hyposmia, REM sleep behaviour disorder, constipation and depression occur. This implies that the disease does not start in the substantia nigra which is supported by the findings of Braak and colleagues who detected Lewy pathology first in the olfactory bulb and medulla oblongata. Thereafter, Lewy bodies spread out to the cortex which explains dementia. Milestones such as visual hallucinations, dementia, admittance to a nursing home and frequent falls indicate that death will occur within the next 3-5 years independent of the age of the patient at the onset of Parkinson's disease. This suggests that the end stage is related to an exponential cell death.
引用
收藏
页码:520 / 524
页数:5
相关论文
共 50 条
  • [31] Does thalamotomy alter the course of Parkinson's disease?
    Tasker, RR
    DeCarvalho, GC
    Li, CS
    Kestle, JRW
    [J]. PARKINSON'S DISEASE, 1996, 69 : 563 - 583
  • [32] Clinical course in Parkinson's disease with elevated homocysteine
    O'Suilleabhain, PE
    Oberle, R
    Bartis, C
    Dewey, RB
    Bottigheri, T
    Diaz-Arrastia, R
    [J]. PARKINSONISM & RELATED DISORDERS, 2006, 12 (02) : 103 - 107
  • [33] The course of depressive symptoms in early Parkinson's disease
    Ravina, B.
    Elm, J.
    Camicioli, R.
    Como, P.
    Marsh, L.
    Jankovic, J.
    Weintraub, D.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S249 - S249
  • [34] Clinical course of patients with idiopathic Parkinson's disease
    Roos, RAC
    Jongen, JCF
    vanderVelde, EA
    [J]. MOVEMENT DISORDERS, 1996, 11 (03) : 236 - 242
  • [35] The course of mild cognitive impairment in Parkinson's disease
    Janvin, C
    Aarsland, D
    Larsen, J
    Hugdahl, K
    [J]. MOVEMENT DISORDERS, 2004, 19 : S155 - S155
  • [36] The time course of semantic activation in Parkinson's disease
    Angwin, AJ
    Chenery, HJ
    Copland, DA
    Murdoch, BE
    Silburn, PA
    [J]. BRAIN AND LANGUAGE, 2004, 91 (01) : 145 - 146
  • [37] Long-term course of Parkinson's disease
    Ebersbach, G.
    [J]. NERVENHEILKUNDE, 2010, 29 (06) : 345 - 350
  • [38] First Neurological Evaluation and Course of Parkinson's Disease
    Rajput, Ali
    Rajput, Michele
    Ferguson, Leslie
    Rajput, Alexander
    [J]. NEUROLOGY, 2016, 86
  • [39] Effect of comorbid Parkinson's disease and Parkinson's disease dementia on the course of idiopathic normal pressure hydrocephalus
    Sakurai, Anri
    Tsunemi, Taiji
    Shimada, Tomoyo
    Kawamura, Kaito
    Nakajima, Madoka
    Miyajima, Masakazu
    Hattori, Nobutaka
    [J]. JOURNAL OF NEUROSURGERY, 2021, 137 (05) : 1302 - 1309
  • [40] Abnormalities of voice quality in the course of disease progression in Parkinson's disease
    Groenheit, W.
    Schlegel, U.
    Skodda, S.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S519 - S520